首页> 美国卫生研究院文献>OncoTargets and therapy >Functional miRNAs in breast cancer drug resistance
【2h】

Functional miRNAs in breast cancer drug resistance

机译:功能性miRNA在乳腺癌耐药中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Owing to improved early surveillance and advanced therapy strategies, the current death rate due to breast cancer has decreased; nevertheless, drug resistance and relapse remain obstacles on the path to successful systematic treatment. Multiple mechanisms responsible for drug resistance have been elucidated, and miRNAs seem to play a major part in almost every aspect of cancer progression, including tumorigenesis, metastasis, and drug resistance. In recent years, exosomes have emerged as novel modes of intercellular signaling vehicles, initiating cell–cell communication through their fusion with target cell membranes, delivering functional molecules including miRNAs and proteins. This review particularly focuses on enumerating functional miRNAs involved in breast cancer drug resistance as well as their targets and related mechanisms. Subsequently, we discuss the prospects and challenges of miRNA function in drug resistance and highlight valuable approaches for the investigation of the role of exosomal miRNAs in breast cancer progression and drug resistance.
机译:由于改善了早期监测和先进的治疗策略,目前因乳腺癌引起的死亡率有所下降;但是,耐药性和复发仍然是成功进行系统治疗的障碍。阐明了引起耐药性的多种机制,miRNA似乎在癌症进展的几乎每个方面都起着主要作用,包括肿瘤发生,转移和耐药性。近年来,外来体已经成为细胞间信号传导媒介的新模式,它们通过与靶细胞膜融合来启动细胞间通讯,传递包括miRNA和蛋白质在内的功能分子。这篇综述特别侧重于列举参与乳腺癌耐药性的功能性miRNA及其靶标和相关机制。随后,我们讨论了耐药性中miRNA功能的前景和挑战,并突出了用于研究外泌体miRNA在乳腺癌进展和耐药性中作用的有价值的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号